The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
21 weeks ago, IMHO don't think it can store this amount........... IMHO.........DYOR
Apollon Formularies PLC (AQSE:APOL) said it completed its high-volume medical cannabis extract processing facility in Negril, Jamaica, which is now producing 20 litres of full-spectrum oil per day.
This will allow the company to significantly increase its inventory in preparation for global export to countries where legal import is allowed.
Dated.............December 2021..................
Apollon Formularies says new Jamaica facility produces 20-litres of high-quality cannabis oil a day.............
https://www.apollon.org.uk/news-and-media/apollon-formularies-says-new-jamaica-facility-produces-20-litres-of-high-quality-cannabis-oil-a-day
No sales so no need for any extra production......................
More talk and no action................ IMHO
Apollon Formularies
@apollon_uk
·
5h
Apollon to significantly increase its inventory in preparation for global export
Increased capacity provides readily available inventory for potential pharmaceutical partners to perform independent clinical trial validation
i would think so if you ever wish to break even. saying that i guess you neither want to loose loads more money so i would'nt go anywhere near it at the moment. the theory, the updates all make sense, great oppourtunity in this industry but personally i need to see some evidence of sales being created and shipments out the door.
the idea, business future and growth in this sector must and is absolutely huge, just actually starting to see it come to life
I have some of these when I bought it as afriag af at a stupid high price. Do I need to lower average.
Apollon Formularies
@apollon_uk
·
2h
Apollon uses the latest state-of-the-art artificial intelligence techniques to optimize strain genetics for medical cannabis formulation development and to analyse patient genomic data to identify new potential biomarkers to triage patients into the correct treatment protocols
Need sales.....................
Apollon Formularies
@apollon_uk
·
41m
#APOL has found that medicinal cannabis can kill prostate cancer cells
Medicinal cannabis formulations were shown to be effective in killing both hormone-resistant and hormone sensitive prostate cancer cells in 3D cell cultures in third party independent laboratory testing.
https://twitter.com/apollon_uk
Apollon Formularies
@apollon_uk
·
8h
After successfully completing the pre-clinical testing on the Apollon medical cannabis cancer formulations, the decision was made to open the first International Cancer and Chronic Pain Institute ("ICCPI") in Kingston, Jamaica
Been looking at getting into APOL. The problem is the true spread. This is not attractive as an investment right now. Looking at todays trade is an example.
Trade price sell 1.26 volume 500,000 value £6300. Bid 2.40 Ask 2.50 at time of trade.
Apollon Formularies
@apollon_uk
·
5h
The combination of our licenses provide us with an opportunity to continue to successfully implement our business plan & achieve the goal of developing, processing, and manufacturing #APOL proprietary formulations & selling cannabis derived pharmaceutical & nutraceutical products
Apollon Formularies
@apollon_uk
·
3h
We expect to negotiate joint license agreement whereby AI Pharma exclusively use Apollon's medical cannabis formulations in combined product in US and Canada, Apollon exclusively use Aion's medicinal (non-psilocybin) mushroom combined product in Europe and Jamaica, where legal.
https://twitter.com/apollon_uk
yep, very positive, outward looking company however we need sales. they seem to be signing up, creating the license agreements across the patch and also looking at volume, production aspects anticipating this increase. i've never bought anymore of this share since the days of lenigas and the sell off. too much of a loss so no point selling. everything looks and sounds great but we need sales and dollars in the bank. if this does happen it will shoot obviously massively
Years of tweets and repeated information and the share keeps tanking..........
Needed sales for years, getting very tied with this outfit................ IMHO
https://twitter.com/apollon_uk/status/1523985506232680448
(2/2) The gradual #medicalcannabis legalisation across Europe is projected to continually increase this value in the next few years. #Apollon aims to achieve European GMP certification in order to expand the exports of its formulations to this burgeoning market
#APOL
(1/2) In @prohibition_p
's European #Cannabis Report, it was estimated that 60k+ people were able to access #medicalcannabis for the first time during 2020, pushing the market in Europe to an estimated worth of €230.7 million at year end
Up 25%
https://stockhouse.com/companies/bullboard/c.aion/aion-therapeutic-inc-com?threadid=34082552
Interesting ... and the price seems reasonable given the combo potential (different therapeutic pathways). Suspect that Aion may need the cash / didn't have it to splash on the joint compound development.
Apollon Formularies
@apollon_uk
·
29m
(3/3) $APOL has purchased the patents via a cash payment & the issuing of ordinary Company shares. In addition, #APOL will pay Aion a 4% royalty fee of Net Revenues on all products produced & sold that are based on the purchased patents
https://twitter.com/apollon_uk